These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12714159)

  • 21. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.
    Larochelle P; Flack JM; Marbury TC; Sareli P; Krieger EM; Reeves RA
    Am J Cardiol; 1997 Dec; 80(12):1613-5. PubMed ID: 9416950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Worldwide clinical experience with ACE inhibitors: the role of quinapril. Proceedings of investigators' meeting. Marbella, Spain, June 10-11, 1989.
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S1-63. PubMed ID: 1691401
    [No Abstract]   [Full Text] [Related]  

  • 23. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of treatment on survival in an animal model of chronic heart failure.
    Bastien N; Lambert C
    Am J Cardiol; 1998 Nov; 82(10A):50S-52S. PubMed ID: 9860360
    [No Abstract]   [Full Text] [Related]  

  • 25. ["Treating to New Targets": plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease].
    Scheen AJ
    Rev Med Liege; 2005 Apr; 60(4):264-7. PubMed ID: 15943105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
    Walther T; Siems WE; Hauke D; Spillmann F; Dendorfer A; Krause W; Schultheiss HP; Tschöpe C
    FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient tirofiban infusion resulting in resolution of intracoronary thrombus.
    Acar G; Sökmen G; Nacar AB; Tuncer C
    Turk Kardiyol Dern Ars; 2008 Apr; 36(3):197. PubMed ID: 18626216
    [No Abstract]   [Full Text] [Related]  

  • 28. [Atorvastatin in treatment of patients with coronary heart disease and dislipidemiya and high general risk: efficiency and safety estimation. Design and main results of ATLANTIKA].
    Mareev VIu; Belenkov IuN; Oganov RG; Barbik-Zhagar B
    Kardiologiia; 2008; 48(11):4-13. PubMed ID: 19076074
    [No Abstract]   [Full Text] [Related]  

  • 29. Additional effects of irbesartan when compared to captopril in the prevention of post-infarction left ventricular dilatation.
    Parkhomenko AN; Irkin OI; Kushnir SP; Bryl ZV; Soliarik O; Shkliar LV
    Acta Cardiol; 2002 Feb; 57(1):61-3. PubMed ID: 11918155
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial).
    März W; Wollschläger H; Klein G; Neiss A; Wehling M
    Am J Cardiol; 1999 Jul; 84(1):7-13. PubMed ID: 10404843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease.
    Schieffer B; Bünte C; Witte J; Hoeper K; Böger RH; Schwedhelm E; Drexler H
    J Am Coll Cardiol; 2004 Jul; 44(2):362-8. PubMed ID: 15261932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study].
    Skvortsov AA; Nasonova SN; Sychev AV; Orlova IaA; Baklanova NA; Masenko VP; Mareev VIu; Belenkov IuN
    Kardiologiia; 2006; 46(7):33-51. PubMed ID: 16883264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
    Li XP; Duan J; Zhao SP; Tan MY; Xu ZM; Zhang DQ
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2399-403. PubMed ID: 17156651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.
    Hope S; Brecher P; Chobanian AV
    Am J Hypertens; 1999 Jan; 12(1 Pt 1):28-34. PubMed ID: 10075381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AT1-receptor antagonists for the treatment of chronic heart failure.
    Baan J
    Cardiovasc Res; 1999 Jan; 41(1):14-5. PubMed ID: 10325947
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol.
    Kanadaşi M; Cayli M; Demirtaş M; Inal T; Demir M; Koç M; Avkaroğullari M; Dönmez Y; Usal A; Alhan CC; San M
    Heart Vessels; 2006 Sep; 21(5):291-7. PubMed ID: 17151816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].
    Pokrovskaia EV; Vaulin NA; Gratsianskiĭ NA; Averkov OV; Deev AD
    Kardiologiia; 2003; 43(1):7-18. PubMed ID: 12891281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.
    Hunninghake D; Bakker-Arkema RG; Wigand JP; Drehobl M; Schrott H; Early JL; Abdallah P; McBride S; Black DM
    J Fam Pract; 1998 Nov; 47(5):349-56. PubMed ID: 9834769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism by which quinapril improves vascular function in coronary artery disease.
    Koh KK; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Am J Cardiol; 1999 Feb; 83(3):327-31. PubMed ID: 10072217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.